Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-glioblastoma activity, significantly reducing tumor size in preclinical trials.

Adding Immunotherapy, Anti-TIGIT in First Line Boosts OS in Esophageal Cancer

SAN FRANCISCO — Adding the novel anti-TIGIT monoclonal antibody tiragolumab plus atezolizumab (Tecentriq) to standard first-line chemotherapy significantly improved survival for patients with advanced esophageal

January 20, 2024

South Park Takes on Wegovy; Decapitated Doc’s Killer Sentenced; Deadliest Superbugs

Note that some links may require registration or subscription. A new special of the TV show “South Park” will take on the rising use of

May 18, 2024

Rhapsody Names Jitin Asnaani as Chief Product Officer

Jitin Asnaani, Chief Product Officer at Rhapsody What You Should Know: – Rhapsody, a digital health enablement company, announced the appointment of Jitin Asnaani as

March 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.